Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.

Romanian journal of internal medicine = Revue roumaine de médecine interne

Volumn 51, Issue 3-4, 2013, Pages 143-147

  Moraru, Ioana G ^a   Portincasa, P ^a   Moraru, A G ^a   Diculescu, M ^a   Dumitrascu D L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; RIFAMYCIN; RIFAXIMIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BLIND LOOP SYNDROME; BREATH ANALYSIS; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HUMAN; IRRITABLE COLON; MALE; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; PILOT STUDY; SMALL INTESTINE; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADULT; AGED; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; BLIND LOOP SYNDROME; BREATH TESTS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTESTINE, SMALL; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PILOT PROJECTS; RIFAMYCINS; TREATMENT OUTCOME;

EID: 84899473578     PISSN: 12204749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)